Addressing Racial And Ethnic Disparities In The Use Of Medications For Opioid Use Disorder

An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID‐19 pandemic

(2021) Phillip M. Hughes et al.   JOURNAL OF RURAL HEALTH

Specialty Substance Use Disorder Treatment Admissions Steadily Increased In The Four Years After Medicaid Expansion

(2020) Brendan Saloner et al.   HEALTH AFFAIRS

Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA

(2020) Amanda J. Abraham et al.   Neurotherapeutics

Interaction effects in the association between methadone maintenance therapy and experiences of racial discrimination in U.S. healthcare settings

(2020) George Pro et al.   PLoS One

Retention of patients in opioid substitution treatment: A systematic review

(2020) Aisling Máire O’Connor et al.   PLoS One

Incidence of Treatment for Opioid Use Disorder Following Nonfatal Overdose in Commercially Insured Patients

(2020) Austin S. Kilaru et al.   JAMA Network Open

Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States

(2020) William C. Goedel et al.   JAMA Network Open

Examining trends in substance use disorder capacity and service delivery by Health Resources and Services Administration-funded health centers: A time series regression analysis

(2020) Nadereh Pourat et al.   PLoS One

Development of a Cascade of Care for responding to the opioid epidemic

(2019) Arthur Robin Williams et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

Buprenorphine Treatment Divide by Race/Ethnicity and Payment

(2019) Pooja A. Lagisetty et al.   JAMA Psychiatry

Prevalence and treatment of opioid use disorders among primary care patients in six health systems

(2019) Gwen Lapham et al.   DRUG AND ALCOHOL DEPENDENCE

The Opioid Crisis in Black Communities

(2018) Keturah James et al.   JOURNAL OF LAW MEDICINE & ETHICS

A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees

(2018) Bradley D. Stein et al.   Substance Abuse

Three-year retention in methadone opioid agonist treatment: A survival analysis of clients by dose, area deprivation, and availability of alcohol and cannabis outlets

(2018) Solmaz Amiri et al.   DRUG AND ALCOHOL DEPENDENCE

Perceived Discrimination in Health Care and Mental Health/Substance Abuse Treatment Among Blacks, Latinos, and Whites

(2017) Vickie M. Mays et al.   MEDICAL CARE

Impact of Medicaid Expansion on Medicaid-covered Utilization of Buprenorphine for Opioid Use Disorder Treatment

(2017) Hefei Wen et al.   MEDICAL CARE

At the Expense of a Life: Race, Class, and the Meaning of Buprenorphine in Pharmaceuticalized “Care”

(2017) Alexandrea E. Hatcher et al.   SUBSTANCE USE & MISUSE

Update on Barriers to Pharmacotherapy for Opioid Use Disorders

(2017) Anjalee Sharma et al.   Current Psychiatry Reports

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

(2017) Luis Sordo et al.   BMJ-British Medical Journal

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

(2017) Luis Sordo et al.   BMJ-British Medical Journal

Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization

(2017) Courtney McKnight et al.   JOURNAL OF ETHNICITY IN SUBSTANCE ABUSE

Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration

(2016) Ajay Manhapra et al.   DRUG AND ALCOHOL DEPENDENCE

Opioid substitution therapy: Lowering the treatment thresholds

(2016) Georgios Kourounis et al.   DRUG AND ALCOHOL DEPENDENCE

The Role of Program Directors in Treatment Practices: The Case of Methadone Dose Patterns in U.S. Outpatient Opioid Agonist Treatment Programs

(2016) Jemima A. Frimpong et al.   HEALTH SERVICES RESEARCH

Changes in Demographics of Patients Seen at Federally Qualified Health Centers, 2005-2014

(2016) Julia B. Nath et al.   JAMA Internal Medicine

Racial/ethnic differences in trends in heroin use and heroin-related risk behaviors among nonmedical prescription opioid users

(2015) Silvia S. Martins et al.   DRUG AND ALCOHOL DEPENDENCE

Integrating buprenorphine maintenance therapy into federally qualified health centers: Real-world substance abuse treatment outcomes

(2013) Marwan S. Haddad et al.   DRUG AND ALCOHOL DEPENDENCE

Blacks And Hispanics Are Less Likely Than Whites To Complete Addiction Treatment, Largely Due To Socioeconomic Factors

(2013) Brendan Saloner et al.   HEALTH AFFAIRS

Variation in Use of Buprenorphine and Methadone Treatment by Racial, Ethnic, and Income Characteristics of Residential Social Areas in New York City

(2013) Helena B. Hansen et al.   JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH

Race/Ethnicity and Geographic Access to Medicaid Substance Use Disorder Treatment Facilities in the United States

(2013) Janet R. Cummings et al.   JAMA Psychiatry

The Physician Clinical Support System-Buprenorphine (PCSS-B): a Novel Project to Expand/Improve Buprenorphine Treatment

(2010) James E. Egan et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Dosage Patterns in Methadone Treatment: Results from a National Survey, 1988-2005

(2008) Harold A. Pollack et al.   HEALTH SERVICES RESEARCH